» Articles » PMID: 34208379

Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity

Overview
Journal Cells
Publisher MDPI
Date 2021 Jul 2
PMID 34208379
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes (T2D) and obesity are relevant worldwide chronic diseases. A common complication in both pathologies is the dysregulation of the insulin-signaling pathway that is crucial to maintain an accurate glucose homeostasis. Flavonoids are naturally occurring phenolic compounds abundant in fruits, vegetables and seeds. Rising evidence supports a role for the flavonoids against T2D and obesity, and at present, these compounds are considered as important potential chemopreventive agents. This review summarizes and studies providing data related to the effects of flavonoids and flavonoid-rich foods on the modulation of the insulin route during T2D and obesity. Notably, few human studies have evaluated the regulatory effect of these phenolic compounds at molecular level on the insulin pathway. In this context, it is also important to note that the mechanism of action for the flavonoids is not fully characterized and that a proper dosage to obtain a beneficial effect on health has not been defined yet. Further investigations will contribute to solve all these critical challenges and will enable the use of flavonoids to prevent, delay or support the treatment of T2D and obesity.

Citing Articles

Characterization of phenolic compounds and evaluation of anti-diabetic potential in L. seeds: and studies.

El-Mernissi R, El Menyiy N, Metouekel A, Zouhri A, El-Mernissi Y, Siddique F Open Life Sci. 2025; 19(1):20221024.

PMID: 39822379 PMC: 11736388. DOI: 10.1515/biol-2022-1024.


Revisiting dietary proanthocyanidins on blood glucose homeostasis from a multi-scale structural perspective.

Wang Y, Zhang L, Xiao H, Ye X, Pan H, Chen S Curr Res Food Sci. 2024; 9:100926.

PMID: 39654810 PMC: 11626065. DOI: 10.1016/j.crfs.2024.100926.


Systematic Review and Meta-Analysis of on Metabolic Disorders: Evidence from Preclinical Studies.

Victoria-Montesinos D, Ballester P, Barcina-Perez P, Garcia-Munoz A Metabolites. 2024; 14(11).

PMID: 39590851 PMC: 11596559. DOI: 10.3390/metabo14110615.


A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases.

Yang C, Wu Y, Qian J, Li J Acta Pharm Sin B. 2024; 14(10):4228-4242.

PMID: 39525586 PMC: 11544391. DOI: 10.1016/j.apsb.2024.05.011.


Effects of Extended Treatment with Liposomes on Metabolic Parameters of Obese Rats.

Patias N, Maia S, Ferreira Y, de Oliveira N, Ferrarini S, Bomfim G Biology (Basel). 2024; 13(10).

PMID: 39452080 PMC: 11505265. DOI: 10.3390/biology13100771.


References
1.
Freitas de Bem G, Costa C, Santos I, Cordeiro V, de Carvalho L, de Souza M . Antidiabetic effect of Euterpe oleracea Mart. (açaí) extract and exercise training on high-fat diet and streptozotocin-induced diabetic rats: A positive interaction. PLoS One. 2018; 13(6):e0199207. PMC: 6007924. DOI: 10.1371/journal.pone.0199207. View

2.
Bowser S, Moore W, McMillan R, Dorenkott M, Goodrich K, Ye L . High-molecular-weight cocoa procyanidins possess enhanced insulin-enhancing and insulin mimetic activities in human primary skeletal muscle cells compared to smaller procyanidins. J Nutr Biochem. 2016; 39:48-58. DOI: 10.1016/j.jnutbio.2016.10.001. View

3.
Santos I, Freitas de Bem G, Cordeiro V, Aguiar da Costa C, de Carvalho L, da Rocha A . Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice. Nutr Res. 2017; 43:69-81. DOI: 10.1016/j.nutres.2017.05.007. View

4.
Zhang Z, Lu J, Zheng Y, Wu D, Hu B, Shan Q . Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. J Nutr Biochem. 2012; 24(6):1008-18. DOI: 10.1016/j.jnutbio.2012.07.009. View

5.
Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M . Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr Metab. 2002; 15(4):222-31. View